{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:42:31Z","timestamp":1792701751390,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pupt.2021.102081","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T15:27:48Z","timestamp":1632497268000},"page":"102081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"given":"Woon Hean","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab K.","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pupt.2021.102081_bib1","doi-asserted-by":"crossref","first-page":"1900541","DOI":"10.1183\/13993003.00541-2019","article-title":"A systematic review of comorbidities and outcomes of adult patients with pleural infection","volume":"54","author":"Cargill","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2021.102081_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1378\/chest.13-1912","article-title":"Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema","volume":"145","author":"S\u00f8gaard","year":"2014","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.pupt.2021.102081_bib3","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa042473","article-title":"U.K. Controlled trial of intrapleural streptokinase for pleural infection","volume":"352","author":"Maskell","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.pupt.2021.102081_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.pupt.2021.102081_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/crj.12068","article-title":"Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials","volume":"8","author":"Nie","year":"2014","journal-title":"Clin. Res. J"},{"issue":"2","key":"10.1016\/j.pupt.2021.102081_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.11-3071","article-title":"Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas","volume":"142","author":"Janda","year":"2012","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.pupt.2021.102081_bib7","first-page":"2019","article-title":"Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema","author":"Altmann","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.pupt.2021.102081_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.pupt.2021.102081_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.pupt.2021.102081_bib10","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.2. 2021 Feb","author":"Higgins","year":"2021"},{"issue":"3","key":"10.1016\/j.pupt.2021.102081_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr. Clin. Trials"},{"issue":"7414","key":"10.1016\/j.pupt.2021.102081_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.pupt.2021.102081_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jamapediatrics.2019.5863","article-title":"Effectiveness of intrapleural tissue plasminogen activator and dornase alfa vs tissue plasminogen activator alone in children with pleural empyema: a randomized clinical trial","volume":"174","author":"Livingston","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"12","key":"10.1016\/j.pupt.2021.102081_bib14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1177\/000313481708301236","article-title":"tPA\/DNase for complicated parapneumonic effusions and empyemas","volume":"83","author":"Maiga","year":"2017","journal-title":"Am. Surg."},{"issue":"3","key":"10.1016\/j.pupt.2021.102081_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00084-2019","article-title":"Comparison of intrapleural use of urokinase and tissue plasminogen activator\/DNAse in pleural infection","volume":"5","author":"B\u00e9dat","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.pupt.2021.102081_bib16","article-title":"Ef\ufb01cacy of intrapleural instillation of \ufb01brinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials","volume":"11","author":"Nie","year":"2014","journal-title":"Clin. Res. J"},{"issue":"6","key":"10.1016\/j.pupt.2021.102081_bib17","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1378\/chest.117.6.1728","article-title":"Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus","volume":"117","author":"Simpson","year":"2000","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pupt.2021.102081_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s004080000002","article-title":"The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema","volume":"178","author":"Light","year":"2000","journal-title":"Lung"},{"issue":"6","key":"10.1016\/j.pupt.2021.102081_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1378\/chest.129.6.1577","article-title":"Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model","volume":"129","author":"Zhu","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.pupt.2021.102081_bib20","doi-asserted-by":"crossref","first-page":"L757","DOI":"10.1152\/ajplung.00501.2017","article-title":"Fibrin turnover and pleural organization: bench to bedside","volume":"314","author":"Komissarov","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"Suppl 2","key":"10.1016\/j.pupt.2021.102081_bib21","doi-asserted-by":"crossref","first-page":"ii41","DOI":"10.1136\/thx.2010.137000","article-title":"Management of pleural infection in adults: British thoracic society pleural disease guideline 2010","volume":"65","author":"Davies","year":"2010","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.pupt.2021.102081_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1183\/09031936.00147214","article-title":"Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection","volume":"46","author":"Hooper","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.pupt.2021.102081_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200312-1740OC","article-title":"Intrapleural streptokinase for empyema and complicated parapneumonic effusions","volume":"170","author":"Diacon","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.pupt.2021.102081_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1164\/ajrccm.159.1.9803094","article-title":"Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: a randomized, double-blind study","volume":"159","author":"Bouros","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.pupt.2021.102081_bib25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00408-015-9807-6","article-title":"Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: a prospective randomized study","volume":"193","author":"Alem\u00e1n","year":"2015","journal-title":"Lung"},{"issue":"2","key":"10.1016\/j.pupt.2021.102081_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/LBR.0000000000000461","article-title":"Concurrent versus sequential intrapleural instillation of tissue plasminogen activator and deoxyribonuclease for pleural infection","volume":"25","author":"Kheir","year":"2018","journal-title":"J Bronchol Interv Pulmonol"},{"key":"10.1016\/j.pupt.2021.102081_bib27","first-page":"1","article-title":"Safety and efficacy of intrapleural tissue plasminogen activator and DNase during extended use in complicated pleural space infections","volume":"2016","author":"McClune","year":"2016","journal-title":"Canc. Res. J."},{"issue":"9","key":"10.1016\/j.pupt.2021.102081_bib28","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1513\/AnnalsATS.201602-127OC","article-title":"Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A single-center experience","volume":"13","author":"Majid","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.pupt.2021.102081_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000443334","article-title":"Management of intrapleural sepsis with once daily use of tissue plasminogen activator and deoxyribonuclease","volume":"91","author":"Mehta","year":"2016","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.pupt.2021.102081_bib30","article-title":"Rethinking the doses of tissue plasminogen activator and deoxyribonuclease administrated concurrently for intrapleural therapy for complicated pleural effusion and empyema","volume":"10","author":"Innabi","year":"2018","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.pupt.2021.102081_bib31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1513\/AnnalsATS.201609-673OC","article-title":"Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project","volume":"14","author":"Popowicz","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.pupt.2021.102081_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/LBR.0000000000000334","article-title":"Mixing it up: coadministration of tPA\/DNase in complicated parapneumonic pleural effusions and empyema","volume":"24","author":"Bishwakarma","year":"2017","journal-title":"J Bronchol Interv Pulmonol"},{"issue":"9","key":"10.1016\/j.pupt.2021.102081_bib33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1513\/AnnalsATS.201407-329OC","article-title":"Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery","volume":"11","author":"Piccolo","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.pupt.2021.102081_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/ejcts\/ezv272","article-title":"EACTS expert consensus statement for surgical management of pleural empyema","volume":"48","author":"Scarci","year":"2015","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg."},{"issue":"6","key":"10.1016\/j.pupt.2021.102081_bib35","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jtcvs.2017.01.030","article-title":"The American Association for Thoracic Surgery consensus guidelines for the management of empyema","volume":"153","author":"Shen","year":"2017","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"12","key":"10.1016\/j.pupt.2021.102081_bib36","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1164\/rccm.201911-2169OC","article-title":"Pleural fluid suPAR levels predict the need for invasive management in parapneumonic effusions","volume":"201","author":"Arnold","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.pupt.2021.102081_bib37","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1513\/AnnalsATS.202001-076OC","article-title":"Intrapleural fibrinolytic therapy versus early medical thoracoscopy for treatment of pleural infection. Randomized controlled clinical trial","volume":"17","author":"Kheir","year":"2020","journal-title":"Ann Am Thorac Soc"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:30:31Z","timestamp":1761082231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553921000936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"alternative-id":["S1094553921000936"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102081","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102081"}}